Form 4 for DGX Quest Diagnostics
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-26 · accession 0001022079-25-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-28 | 2025-02-27 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $172.61 | -824 | 69.2K | -1% | -$142.2K | |
| 2025-02-28 | 2025-02-26 | DGX | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $171.75 | -455 | 70.0K | -0.6% | -$78.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-27 | S | D | 824 | $172.61 | 69,178 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-26 | F | D | 455 | $171.75 | 70,002 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |